Optical Genome Mapping for a Patient with a Congenital Disorder and Chromosomal Translocation

Cytogenet Genome Res. 2022;162(11-12):617-624. doi: 10.1159/000531103. Epub 2023 May 18.

Abstract

We performed optical genome mapping (OGM), a newly developed cytogenetic technique, for a patient with a disorder of sex development (DSD) and a 46,XX,t(9;11)(p22;p13) karyotype. The results of OGM were validated using other methods. OGM detected a 9;11 reciprocal translocation and successfully mapped its breakpoints to small regions of 0.9-12.3 kb. OGM identified 46 additional small structural variants, only three of which were detected by array-based comparative genomic hybridization. OGM suggested the presence of complex rearrangements on chromosome 10; however, these variants appeared to be artifacts. The 9;11 translocation was unlikely to be associated with DSD, while the pathogenicity of the other structural variants remained unknown. These results indicate that OGM is a powerful tool for detecting and characterizing chromosomal structural variations, although the current methods of OGM data analyses need to be improved.

Keywords: Breakpoint; Chromosomal translocation; Genomic rearrangement; Optical genome mapping; Whole-genome sequencing.

Publication types

  • Case Reports